Lataa...
Crizotinib targets in glioblastoma stem cells
Glioblastoma stem cells (GSCs) are believed to be involved in the mechanisms of tumor resistance, therapeutic failures, and recurrences after conventional glioblastoma therapy. Therefore, elimination of GSCs might be a prerequisite for the development of successful therapeutic strategies. ALK, ROS1,...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5673924/ https://ncbi.nlm.nih.gov/pubmed/28960893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1167 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|